166 related articles for article (PubMed ID: 17015057)
1. Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis.
Kaneshiro Y; Oda Y; Iwakiri K; Masada T; Iwaki H; Hirota Y; Kondo K; Takaoka K
Clin Pharmacol Ther; 2006 Oct; 80(4):396-402. PubMed ID: 17015057
[TBL] [Abstract][Full Text] [Related]
2. [Hepatic CYP3A activity in association with development of osteonecrosis of the femoral head].
Kaneshiro Y; Takaoka K
Clin Calcium; 2007 Jun; 17(6):902-9. PubMed ID: 17548930
[TBL] [Abstract][Full Text] [Related]
3. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model.
Masada T; Iwakiri K; Oda Y; Kaneshiro Y; Iwaki H; Ohashi H; Takaoka K
J Orthop Res; 2008 Jan; 26(1):91-5. PubMed ID: 17787012
[TBL] [Abstract][Full Text] [Related]
4. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
[TBL] [Abstract][Full Text] [Related]
5. Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis.
Nafziger AN; Bertino JS
Clin Pharmacol Ther; 2007 Oct; 82(4):379; author reply 380. PubMed ID: 17851579
[No Abstract] [Full Text] [Related]
6. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
7. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam.
Chaobal HN; Kharasch ED
Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619
[TBL] [Abstract][Full Text] [Related]
8. Comparison of midazolam and simvastatin as cytochrome P450 3A probes.
Chung E; Nafziger AN; Kazierad DJ; Bertino JS
Clin Pharmacol Ther; 2006 Apr; 79(4):350-61. PubMed ID: 16580903
[TBL] [Abstract][Full Text] [Related]
9. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
Chalasani N; Gorski JC; Patel NH; Hall SD; Galinsky RE
Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
[TBL] [Abstract][Full Text] [Related]
10. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Masica AL; Mayo G; Wilkinson GR
Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
[TBL] [Abstract][Full Text] [Related]
11. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
Kurnik D; Wood AJ; Wilkinson GR
Clin Pharmacol Ther; 2006 Sep; 80(3):228-34. PubMed ID: 16952489
[TBL] [Abstract][Full Text] [Related]
12. [Clinical research of correlation between osteonecrosis and steroid].
Li ZR; Sun W; Qu H; Zhou YX; Dou BX; Shi ZC; Zhang NF; Cheng XG; Wang DL; Guo WS
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(16):1048-53. PubMed ID: 16194330
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Steroid-Induced Osteonecrosis of The Femoral Head and Hepatic CYP3A Activity: A Systematic Review and Meta-Analysis.
Guo FQ; Deng M
J Invest Surg; 2019 Mar; 32(2):118-126. PubMed ID: 29120670
[TBL] [Abstract][Full Text] [Related]
14. Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose.
Tokuhara Y; Wakitani S; Oda Y; Kaneshiro Y; Masada T; Kim M; Kadoya Y; Azuma T; Takaoka K
J Orthop Sci; 2009 Nov; 14(6):794-800. PubMed ID: 19997828
[TBL] [Abstract][Full Text] [Related]
15. Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans.
Okudaira T; Kotegawa T; Imai H; Tsutsumi K; Nakano S; Ohashi K
J Clin Pharmacol; 2007 Jul; 47(7):871-6. PubMed ID: 17585116
[TBL] [Abstract][Full Text] [Related]
16. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients.
Wyen C; Fuhr U; Frank D; Aarnoutse RE; Klaassen T; Lazar A; Seeringer A; Doroshyenko O; Kirchheiner JC; Abdulrazik F; Schmeisser N; Lehmann C; Hein W; Schömig E; Burger DM; Fätkenheuer G; Jetter A
Clin Pharmacol Ther; 2008 Jul; 84(1):75-82. PubMed ID: 18183034
[TBL] [Abstract][Full Text] [Related]
17. A muCT analysis of the femoral bone stock in osteonecrosis of the femoral head compared to osteoarthrosis.
Beckmann J; Matsuura M; Grässel S; Köck F; Grifka J; Tingart M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):501-5. PubMed ID: 18560853
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe.
Ma JD; Nafziger AN; Rhodes G; Liu S; Gartung AM; Bertino JS
J Clin Pharmacol; 2006 Jan; 46(1):103-8. PubMed ID: 16397289
[TBL] [Abstract][Full Text] [Related]
19. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
Liangpunsakul S; Kolwankar D; Pinto A; Gorski JC; Hall SD; Chalasani N
Hepatology; 2005 May; 41(5):1144-50. PubMed ID: 15841467
[TBL] [Abstract][Full Text] [Related]
20. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway.
Jiang Y; Zhang Y; Zhang H; Zhu B; Li P; Lu C; Xu Y; Chen W; Lin N
Exp Biol Med (Maywood); 2014 Mar; 239(3):347-55. PubMed ID: 24510055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
